A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease

L. J. Thal, G. Schwartz, M. Sano, M. Weiner, D. Knopman, L. Harrell, S. Bodenheimer, M. Rossor, M. Philpot, J. Schor, A. Goldberg

Research output: Contribution to journal › Article › peer-review

72 Scopus citations

Fingerprint

Dive into the research topics of 'A multicenter double-blind study of controlled-release physostigmine for the treatment of symptoms secondary to Alzheimer's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences